PubMed ID:
9518395
Public Release Type:
Journal
Publication Year: 1998
DOI:
https://doi.org/10.7326/0003-4819-128-7-199804010-00001
Studies:
Diabetes Control and Complications Trial
Although insulin secretion is severely decreased in most patients with type 1 diabetes, levels of residual insulin secretion often vary early in the disease. The significance of residual insulin secretion with regard to metabolic control and to long-term complications and ways to preserve such secretion are not well understood.